Obregón-Giraldo M, Barrientos-Álvarez LS, Henao-Villada A, Valencia-Palacio E, Trujillo-Honeysberg M

Language: Spanish
References: 15
Page: 191-194
PDF size: 223.40 Kb.

ABSTRACT

Introduction: leptospirosis is one of the most widely distributed zoonotic diseases in the world, however, its diagnosis can be difficult because the clinical manifestations are diverse. We present a school-age patient with leptospirosis, to promote early diagnosis in similar cases. Case presentation: 11-year-old male patient with fever, asthenia, adynamia, headache, edema in the lower limbs, choluria, myalgia in the gastrocnemius, as well as rash on the trunk and all four extremities. Different infections were ruled out, such as dengue, COVID-19, and syphilis. Given the persistence of symptoms for more than seven days, and due to the history of contact with domestic animals, leptospirosis was suspected. It was confirmed by elevation of specific IgM antibodies for Leptospira and a positive urine PCR result for Leptospira spp. 48 hours after starting antimicrobial treatment, the patient began to improve, reaching complete resolution. Conclusions: leptospirosis is a disease that has a variable clinical course, so it should always be considered as part of the differential diagnosis of patients with febrile syndrome.

REFERENCES

1. Pérez-García J, Arboleda M, Agudelo-Flórez P. Leptospirosis infantil en pacientes con síndrome febril en la región de Urabá, Colombia. Rev Peru Med Exp Salud Publica. 2016; 33(4): 745-750.

2. Verdasquera CD, Alpízar GD, Vázquez PAL, Romero GAL, Galí BL, Abad LY, Fernández MC. Evaluación del nivel de conocimientos sobre leptospirosis humana en pediatras del hospital "William Soler", 2009. Rev Enfer Infec Pediatr. 2011; 24.25(95): 95-104.

3. Day N. Leptospirosis: Epidemiology, microbiology, clinical manifestations, and diagnosis. UptoDate. 2022. pp. 1-29.

4. Parra E, Ospina-Marínez ML, Barros-Linan EC, Durán-Romero MA, Duarte C. Guía para la vigilancia por laboratorio de Leptospira spp. Colombia: Instituto Nacional de Salud; 2017. pp. 1-16.

5. Nieves DJ. Leptospirosis. In: Kimberlin DW, Brady MT, Kimberlin DW, Brady MT, Jackson MA, Long SS. Red Book: 2018. Report of the committee on infectious diseases. 31st ed. Itaska, IL: American Academy of Pediatrics; 2018. pp. 508-511.

6. Aranzazu Ceballos AD, Apraez Henao L, Ortiz Marín DC. Leptospirosis en pediatría, un diagnóstico a tener en cuenta. Rev Chil Infectol. 2020; 37(6): 728-738.

7. Davies HD, Simonsen KA. Leptospira. Nelson. Tratado de pediatría. 2020; 21: 1601-1603.

8. Tomari K, Toyokawa T, Takahashi T, Kakita T, Okano S, Kyan H et al. Childhood leptospirosis in an industrialized country: Population-based study in Okinawa, Japan. PLoS Negl Trop Dis. 2018; 12(3): e0006294.

9. Samudio DGC, Cuevas C, Brizuela ES, Coronel J. Leptospirosis en pediatría. A propósito de un caso. Pediatr (Asunción). 2010; 37(1): 48-51.

10. Day N. Leptospirosis: treatment and prevention. UptoDate. 2022. pp. 1-10

11. Céspedes ZM. Leptospirosis: enfermedad zoonótica emergente. Rev Perú Med Exp Salud Publica. 2005; 22(4): 290-307.

12. Haidar G, Singh N. Fever of unknown origin. N Engl J Med. 2022; 386(5): 463-477.

13. Cedano J, Rodríguez S, Kujundzic W, Arana JS et al. Caracterización clínica de la leptospirosis grave en un hospital de alta complejidad de Cali, Colombia, 2010-2016. Biomédica. 2019; 39(1): 108-116.

14. Pulido-Villamarín A, Carreño-Beltrán G, Mercado-Reyes M, Ramírez-Bulla P. Situación epidemiológica de la leptospirosis humana en Centroamérica, Suramérica y el Caribe. Univ Sci. 2014; 19(3): 247-264.

15. Toyokawa T, Ohnishi M, Koizumi N. Diagnosis of acute leptospirosis. Expert Rev Anti Infect Ther. 2011; 9(1): 111-121.